Clinical trial
Investigation of the Activity of Novel Compounds for the Treatment of Myeloma and Mechanisms of Drug Resistance to Current Therapies
NCT05968417 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Activity of Novel Compounds for the Treatment of Myeloma and Mechanisms of Drug Resistance to Current Therapies
- Lead sponsor
- Institute of Cancer Research, United Kingdom
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 22, 2020
- Completion date
- February 28, 2035
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.